AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 2(3), 1953, pp. 429-444
Copyright © 1953 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyles, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyles, D. E.

The Present Status of the Chemotherapy of Toxoplasmosis

Don E. Eyles
Department of Health, Education and Welfare, National Institutes of Health, National Microbiological Institute, Laboratory of Tropical Diseases, Medical School of the University of Tennessee1

Since the discovery of Toxoplasma gondii as a cause of human disease, a number of investigators have attempted to find chemotherapeutic agents effective against this parasite. These efforts are continuing and some progress has been and is being made. For that reason I have chosen to summarize this work up to the present time as my contribution to this symposium on toxoplasmosis.

We consider it important to find effective chemotherapeutic agents, for, as diagnostic procedures improve and become more universally used, an increasingly large number of cases of disease will be found at an early stage. Admittedly, it is unlikely that any drug could do more than arrest the progress of the subacute or chronic congenital infection; however, it is reasonable to suppose that some congenital cases may be recognized at a stage sufficiently early to be amenable to treatment. Certainly, effective drugs would be important also in acute infections acquired after birth in either children or adults if we can recognize these infections sufficiently early in the course of the disease.


1 874 Union Avenue, Memphis 3, Tennessee.




This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
M. J. HOGAN
Ocular Toxoplasmosis: Clinical and Laboratory Diagnosis; Evaluation of Immunologic Tests; Treatment
Arch Ophthalmol, March 1, 1956; 55(3): 333 - 345.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
J. V. CASSADY, C. S. CULBERTSON, and J. W. BAHLER
The Etiology of Retinochoroiditis and Uveitis: Importance of the Dye (Methylene Blue) Cytoplasm-Modifying Antibody Test for Toxoplasmosis
Arch Ophthalmol, July 1, 1955; 54(1): 28 - 36.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
H. P. WAGENER
DISEASES OF THE RETINA AND OPTIC NERVE
Arch Ophthalmol, May 1, 1955; 53(5): 722 - 754.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1953 by the American Society of Tropical Medicine and Hygiene.